ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
| Revenue (TTM) | $5.40B |
| Gross Profit (TTM) | $3.32B |
| EBITDA | $2.02B |
| Operating Margin | 35.20% |
| Return on Equity | 25.70% |
| Return on Assets | 14.70% |
| Revenue/Share (TTM) | $36.90 |
| Book Value | $43.39 |
| Price-to-Book | 5.21 |
| Price-to-Sales (TTM) | 6.17 |
| EV/Revenue | 5.99 |
| EV/EBITDA | 15.49 |
| Quarterly Earnings Growth (YoY) | 14.50% |
| Quarterly Revenue Growth (YoY) | 11.00% |
| Shares Outstanding | $145.68M |
| Float | $144.78M |
| % Insiders | 0.51% |
| % Institutions | 68.61% |
Volatility is currently contracting